Grant: Project Grant
University of British Columbia
$784,126.00
Tissue resident and migratory group 2 innate lymphoid cells in health and disease
FY 2019-20
Summary
Inhaled allergens stimulate a population of innate lymphocytes called ILC2. Stimulated ILC2s proliferate and produce factors called cytokines that drive allergic diseases of the lung including asthma. Unlike most other lymphocytes, ILC2s do not normally circulate throughout our body. Lung ILC2s are generated soon after birth and stay in the lung throughout life.
We have recently found a population of immature lymphocytes, which are capable of becoming ILC2, in the lung of of very young mice, We have also found that some stimulated lung ILC2s circulate and eventually migrate to the liver. Now we plan to find out whether the immature lymphocyte population is the source of lung resident ILC2s and what lung-derived ILC2s in the liver do and how they may influence liver diseases. This project will explore the possible connection between lung diseases and liver conditions mediated by ILC2s. Our results will have important implications to lung and liver diseases.
Department
Program
Project Grant
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
419240
Name
Takei Fumio
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Immunology & Transplantation
Projecttitle
Tissue resident and migratory group 2 innate lymphoid cells in health and disease
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$784,126
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Fibrosis; Hepatitis; Innate Lymphocytes; Liver; Lung; Lymphocyte Development; Migration; Neonate; Tissue Resident
Abstract
Inhaled allergens stimulate a population of innate lymphocytes called ILC2. Stimulated ILC2s proliferate and produce factors called cytokines that drive allergic diseases of the lung including asthma. Unlike most other lymphocytes, ILC2s do not normally circulate throughout our body. Lung ILC2s are generated soon after birth and stay in the lung throughout life.
We have recently found a population of immature lymphocytes, which are capable of becoming ILC2, in the lung of of very young mice, We have also found that some stimulated lung ILC2s circulate and eventually migrate to the liver. Now we plan to find out whether the immature lymphocyte population is the source of lung resident ILC2s and what lung-derived ILC2s in the liver do and how they may influence liver diseases. This project will explore the possible connection between lung diseases and liver conditions mediated by ILC2s. Our results will have important implications to lung and liver diseases.
Competitiondate
202003
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Takei, Fumio
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $784,126~ $0~